Tower Research Capital LLC TRC Has $286,000 Stock Position in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Tower Research Capital LLC TRC lowered its stake in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH – Get Rating) by 36.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,134 shares of the company’s stock after selling 4,075 shares during the period. Tower Research Capital LLC TRC owned approximately 0.14% of SPDR S&P Pharmaceuticals ETF worth $286,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also recently made changes to their positions in XPH. JPMorgan Chase & Co. raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 117.4% in the 1st quarter. JPMorgan Chase & Co. now owns 60,339 shares of the company’s stock worth $2,731,000 after acquiring an additional 32,581 shares during the last quarter. Bank of Montreal Can raised its holdings in shares of SPDR S&P Pharmaceuticals ETF by 8.4% in the 1st quarter. Bank of Montreal Can now owns 12,875 shares of the company’s stock worth $598,000 after acquiring an additional 1,000 shares during the last quarter. UBS Group AG increased its stake in SPDR S&P Pharmaceuticals ETF by 8.5% in the 1st quarter. UBS Group AG now owns 31,160 shares of the company’s stock valued at $1,411,000 after buying an additional 2,438 shares during the last quarter. Atria Wealth Solutions Inc. purchased a new stake in SPDR S&P Pharmaceuticals ETF in the 1st quarter valued at about $211,000. Finally, Captrust Financial Advisors increased its stake in SPDR S&P Pharmaceuticals ETF by 23.2% in the 1st quarter. Captrust Financial Advisors now owns 1,388 shares of the company’s stock valued at $63,000 after buying an additional 261 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Trading Down 0.4 %

NYSEARCA:XPH opened at $42.51 on Friday. SPDR S&P Pharmaceuticals ETF has a 52 week low of $37.94 and a 52 week high of $46.61. The firm has a 50-day moving average price of $42.33 and a two-hundred day moving average price of $42.07.

About SPDR S&P Pharmaceuticals ETF

(Get Rating)

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.